Where MSM is permitted, and what the file must show
MSM is sold as a food supplement ingredient in the EU, US and UK, but it is not a vitamin or mineral and is not on the EU Annex II nutrient list. The file must show the route to market, contaminant results against destination limits, a label naming the substance and claims inside the food-law boundary. This page maps those checks at the date of review; the legal text in force in the destination market governs.
MSM is not an Annex II nutrient; its file has to prove the route to market, the limits and the label, not a nutrient listing.
Three questions, not one
Selling MSM into a market raises three questions. What is the legal route for this substance? Which contaminant limits apply to the finished supplement? And what may the label and the claim say? A positive answer to one does not answer the others.
The route can be a national food-supplement rule, a novel-food assessment or a dietary-ingredient basis. The limits are written for the product as sold, not for the raw material. The label rule names the substance and amount; the claim rule decides what may be said beyond that.
European Union
MSM is not listed in Annex I or Annex II to Directive 2002/46/EC, which cover vitamins and minerals. It is used as an “other substance” in food supplements under general food law and national rules. The EU Novel Food Catalogue has recorded methylsulfonylmethane as not novel in food supplements; that catalogue entry is a Commission information tool, not an authorisation, and the destination Member State’s rules still apply.
The supplement label follows Regulation (EU) No 1169/2011 and the particulars of Directive 2002/46/EC: the words food supplement, the substance and amount per portion, the dose warning, the children warning and the varied-diet statement. MSM has no nutrient reference value, so a % NRV figure would have nothing to refer to.
Contaminants fall under Regulation (EU) 2023/915. Lead is limited to 3.0 mg/kg, cadmium to 1.0 mg/kg and mercury to 0.10 mg/kg in food supplements; there is no harmonised EU maximum for arsenic, so the buyer sets one. A raw-material specification at the same figure as the finished-product limit leaves no room for the rest of the formula.
United States
In the US, MSM is sold as a dietary ingredient, and the file should state the basis: marketing before 15 October 1994, a new dietary ingredient notification, or a GRAS conclusion that covers the intended use. FDA GRAS Notice 229 covers methylsulfonylmethane in certain conventional foods at specified levels, not every supplement use; the basis must match the product.
The Supplement Facts panel is set by 21 CFR 101.36. MSM appears as a dietary ingredient with the amount per serving; it has no Daily Value, so no % Daily Value is declared. The source and any excipients belong in the ingredient list. 21 CFR 111 requires identity testing, supplier qualification and batch records; the buyer’s own identity test on receipt is part of the file.
There is no federal maximum level for lead in dietary supplements. California’s Proposition 65 supplies an exposure limit, and state rules can differ. A structure/function statement is allowed if it is truthful and substantiated, and it must carry the DSHEA disclaimer; a disease claim falls outside the supplement framework.
United Kingdom
Great Britain applies a retained food-supplement framework. The Food Supplements (England) Regulations 2003 set the vitamin and mineral forms; MSM is an “other substance” sold under general food law. Check the novel-food position against Food Standards Agency guidance for Great Britain, because the GB and EU catalogues can diverge.
Contaminants in GB are retained from Regulation (EC) No 1881/2006 rather than replaced by the EU’s 2023/915, with the same supplement figures at the date of this note. Labelling follows the Food Information Regulations 2014 and the 2003 Regulations; the label carries the UK address of the food business operator. The GB claims register is separate from the EU register, and Northern Ireland continues to apply the EU rules under the Windsor Framework.
The contaminant table
| Element | EU | US | UK |
|---|---|---|---|
| Lead | 3.0 mg/kg | No federal supplement maximum; Prop 65 may apply | 3.0 mg/kg retained |
| Cadmium | 1.0 mg/kg | No federal supplement maximum | 1.0 mg/kg retained |
| Mercury | 0.10 mg/kg | No federal supplement maximum | 0.10 mg/kg retained |
| Arsenic | Not harmonised; Member State limits possible | No federal supplement maximum | Not harmonised |
The catalog raw-material limits are Pb ≤3, As ≤2, Cd ≤1 and Hg ≤0.1 mg/kg. They are not the finished-product limits in the table. If MSM is 5% of the daily portion, a raw material at the lead limit contributes a small share of the finished-product figure; if it is most of the portion, it can use up the allowance. Do the arithmetic from the daily dose and the ingredient share.
What the label and claim may say
No health claim for MSM is authorised in the EU register under Regulation (EU) No 432/2012 at the date of this review, and the GB register has no MSM claim either. Any statement beyond the name and the amount must be general and truthful, must not be medicinal, and must not carry a health claim. “No disease-related claim” is the simplest rule for the artwork brief.
In the US, a structure/function statement can describe the role of the ingredient in normal structure or function if it is substantiated and carries the DSHEA disclaimer. The marketer must notify FDA within 30 days of first marketing it. A disease claim is not permitted in any of these markets.
The specification and certificate are not claims; assay, purity and melting range do not become a health claim, and the label copy should not either.
The document pack
- Lot COA with method, release limit and result for each line.
- Specification and TDS naming the grade, particle size and pack.
- SDS in the 16-section format.
- EU/UK novel-food status note, with the catalogue reference and the date checked.
- US dietary-ingredient basis: pre-1994 evidence, NDI notification or GRAS conclusion.
- Heavy-metal and microbiology reports, plus a residual DMSO and sulfate statement where the route or the buyer calls for it.
- Allergen, GMO, irradiation and animal-origin statements.
- Stability summary and the storage statement.
Each document should carry the lot code, or name the lot it belongs to. A TDS written for the catalog and a COA written for one lot match only if the grade, pack and specification revision agree.
What to check before the first order
- Is the route to market documented for the destination, and is the novel-food position current?
- Do the contaminant results meet the finished-product limit at the daily dose?
- Does the label name methylsulfonylmethane and the amount per portion, without a % NRV?
- Is every claim inside the EU/GB register or a disclaimed US structure/function statement?
- Is the US dietary-ingredient basis matched to the intended use?
- Does every document carry the lot code, grade and specification revision?
The COA page lists the release lines; the identity page covers the tests that prove the substance; the MSM hub carries the catalog specification. The EU, US and UK notes expand each market.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation